| 0 (0%) | 07-28 22:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 28.9 | 1-year : | 29.16 |
| Resists | First : | 24.74 | Second : | 24.96 |
| Pivot price | 24.56  |
|||
| Supports | First : | 24.37 | Second : | 20.28 |
| MAs | MA(5) : | 24.49 |
MA(20) : | 24.61 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 37.4 |
D(3) : | 21.6 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 25.01 | Low : | 24.24 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IBTR ] has closed below upper band by 41.4%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 24.65 - 24.75 | 24.75 - 24.85 |
| Low: | 24.33 - 24.43 | 24.43 - 24.54 |
| Close: | 24.42 - 24.61 | 24.61 - 24.79 |
Thu, 11 Jun 2026
Plan ahead: timely IBTR submission ensures smooth international business travel - Auburn University
Fri, 13 Feb 2026
Evaluation of methods to classify ipsilateral breast tumour recurrences as local recurrence or new primary tumour - Nature
Mon, 30 Jun 2025
Partial-Breast Radiotherapy After Breast-Conserving Surgery: 10-Year Outcomes - The ASCO Post
Fri, 02 May 2025
IBTR Rates With Margin Widths Not Clinically Meaningful in Breast Cancer - CancerNetwork
Tue, 11 Feb 2025
Breast Cryoablation Inhibits Recurrence, Enhances Survival in Breast Cancer - CancerNetwork
Wed, 04 Oct 2023
In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survival - MedPage Today
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|